Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
, adalimumab, infliximab, certolizumab, canakinumab, tocilizumab, sarilumab, and secukinumab) are monoclonal antibodies and have special targets like tumor necrosis factor (TNF)-, interleukin (IL)-6, IL-1, and IL-17 ( Although the above mentioned DMARDs have been quite successful in mitigating RA, it is still an undeniable fact that a significant proportion of patients could experience treatment failure, including nonresponse and limited efficacy ( With the deepening of research and exploration, many molecules are identified to exert important roles and bring novel insights to prevent RA
Deltoid (Shoulder Muscle): The thick, central portion of the shoulder muscle (less common for self-injection)
Elsevier (2018)
/ month $360.00 Original price was: $360.00.$250.00Current price is: $250.00
You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you
US$ 24.70
US$ 29.12
US$ 22.59
US$ 26.64
US$ 28.46
US$ 20.79
US$ 27.69
US$ 27.95
